Thomas Ramdahl

Non-Executive Director / Clarity Pharmaceuticals

Dr Ramdahl is a pharmaceutical executive with over 20 years of clinical and development experience. In 2001, he became President and the first CEO of Algeta ASA. When Dr Ramdahl joined Algeta, he was one of six employees and he was involved in serving in several senior positions within the company through to and post the acquisition of Algeta by Bayer AG in 2014. Dr Ramdahl has authored more than 40 publications and is a co-inventor of several patents. Dr Ramdahl currently serves as Chairman of Precirix (Belgium) and AppSens AS (Norway).

Lists and Charts

Total Shareholder Return as at 12/03/26

Rank	Company	1 Yr	5 Yr
1000^th	Clarity Pharmaceuticals	1.41%	0%
1001^st	Growthpoint Properties Australia	1.06%	0.43%
1002^nd	Djerriwarrh Investments	1%	4.87%
998^th	Perpetual Credit Income Trust	2%	8.15%
999^th	Contact Energy	1.99%	9.2%

View Full List

1675 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

Person Activity

NEW ROLE: Non-Executive Director, Clarity Pharmaceuticals

07 Apr 2022

Related Information

Access to our data for Thomas Ramdahl is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Thomas Ramdahl is linked to 1 organisation which is included in 1 list - Public Companies - non WA.

To see the data you will need to Subscribe.